Waycross Investment Management Co Purchases Shares of 4,684 CME Group Inc. $CME

Posted by George Bondi on Sep 3rd, 2026

Waycross Investment Management Co acquired a new position in CME Group Inc. (NASDAQ:CME – Free Report) during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm acquired 4,684 shares of the financial services provider’s stock, valued at approximately $1,034,000.

A number of other hedge funds also recently made changes to their positions in the stock. Empowered Funds LLC increased its stake in shares of CME Group by 11.5% in the first quarter. Empowered Funds LLC now owns 10,027 shares of the financial services provider’s stock worth $2,660,000 after purchasing an additional 1,037 shares in the last quarter. Marshall Wace LLP lifted its stake in shares of CME Group by 103.1% during the 2nd quarter. Marshall Wace LLP now owns 3,692 shares of the financial services provider’s stock valued at $1,018,000 after buying an additional 121,707 shares in the last quarter. Federated Hermes Inc. boosted its holdings in CME Group by 1,325.2% in the 2nd quarter. Federated Hermes Inc. now owns 23,572 shares of the financial services provider’s stock worth $6,497,000 after buying an additional 21,918 shares during the period. Nebula Research & Development LLC bought a new position in CME Group in the 2nd quarter worth $992,000. Finally, The Manufacturers Life Insurance Company increased its stake in CME Group by 2.6% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 287,876 shares of the financial services provider’s stock worth $79,344,000 after buying an additional 7,397 shares in the last quarter. 87.75% of the stock is currently owned by institutional investors.

Insider Activity at CME Group

In other news, Director William R. Shepard bought 325 shares of the stock in a transaction dated Thursday, June 25th. The stock was purchased at an average cost of $230.57 per share, for a total transaction of $74,935.25. Following the transaction, the director owned 260,442 shares of the company’s stock, valued at $60,050,111.94. The trade was a 0.12% increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Corporate insiders own 0.30% of the company’s stock.

Analysts Set New Price Targets

CME has been the topic of a number of recent analyst reports. Bank of America raised their price target on CME Group from $226.00 to $230.00 and gave the company an “underperform” rating in a report on Thursday, July 23rd. Erste Group Bank lowered CME Group from a “buy” rating to a “hold” rating in a research note on Friday, June 5th. Piper Sandler cut their target price on CME Group from $329.00 to $295.00 and set an “overweight” rating for the company in a research report on Wednesday, July 15th. Morgan Stanley lifted their target price on CME Group from $324.00 to $330.00 and gave the company an “overweight” rating in a research note on Thursday, July 23rd. Finally, Weiss Ratings cut CME Group from a “buy (b-)” rating to a “hold (c+)” rating in a report on Tuesday, August 11th. Nine research analysts have rated the stock with a Buy rating, six have given a Hold rating and three have assigned a Sell rating to the stock. According to data from MarketBeat, CME Group presently has an average rating of “Hold” and a consensus target price of $288.56.

Get Our Latest Stock Report on CME

CME Group Trading Down 3.0%

Shares of CME Group stock opened at $277.77 on Thursday. CME Group Inc. has a twelve month low of $218.31 and a twelve month high of $329.16. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.13. The business has a 50-day moving average price of $256.41 and a 200-day moving average price of $278.50. The firm has a market cap of $99.88 billion, a price-to-earnings ratio of 23.56, a PEG ratio of 3.38 and a beta of 0.24.

CME Group (NASDAQ:CME – Get Free Report) last posted its earnings results on Wednesday, July 22nd. The financial services provider reported $2.99 EPS for the quarter, topping analysts’ consensus estimates of $2.91 by $0.08. CME Group had a return on equity of 15.60% and a net margin of 63.30%.The company had revenue of $1.71 billion for the quarter, compared to the consensus estimate of $1.68 billion. During the same period in the previous year, the business earned $2.96 earnings per share. The firm’s revenue for the quarter was up .8% on a year-over-year basis. Equities research analysts anticipate that CME Group Inc. will post 12.27 EPS for the current fiscal year.

CME Group Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, September 25th. Stockholders of record on Wednesday, September 9th will be issued a dividend of $1.30 per share. This represents a $5.20 annualized dividend and a dividend yield of 1.9%. The ex-dividend date of this dividend is Wednesday, September 9th. CME Group’s dividend payout ratio is 44.11%.

CME Group Company Profile

(Free Report)

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.